InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
5
Disclosed sells
14
T+90 hit rate
33%
T+90 mean return
-15.1%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by FLATLEY JAY T, Director. Insider active across 6 companies, notably Illumina, INC.. Cumulatively, 40 reports have been published. Split: 5 buys · 14 sells. Total volume traded: €9.3m. History available since 4 May 2021. The latest transaction was disclosed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations40 total
17,445 sharesClass A Common StockSEC:0001189130-26-000007:0
6,408 shares0Common StockSEC:0001189130-26-000005:0
24,224 shares0Class A Common StockSEC:0001628280-24-029354:0
5,967 shares0Common StockSEC:0001714899-24-000135:0
18,208 shares0Class A Common StockSEC:0001209191-23-039521:0
4,216 shares0Common StockSEC:0001714899-23-000095:0
144,789 sharesCommon StockSEC:0001645842-22-000149:0
43,018 sharesCommon StockSEC:0001104659-22-076874:0
8,960 shares0Class A Common StockSEC:0001209191-22-035133:0
5,986 shares0Common StockSEC:0001714899-22-000092:0
40,000 shares@ US$29.310.0045% mcap28.6% of flowClass A Common StockSEC:0001209191-22-032925:0
Ideal exit: 20 Feb 2023 (T+270)
100,000 shares@ US$10.0050.0% of flowCommon StockSEC:0001645842-21-000040
Ideal exit: 14 Aug 2022 (T+270)
100,000 shares@ US$10.0050.0% of flowCommon StockSEC:0001645842-21-000040:0
Ideal exit: 14 Aug 2022 (T+270)
20,000 shares@ US$78.000.0056% mcap35.7% of flowClass A Common StockSEC:0000899243-21-045169:0
Ideal exit: 12 Aug 2022 (T+270)
20,000 shares@ US$78.0035.7% of flowClass A Common StockSEC:0000899243-21-045169
Ideal exit: 12 Aug 2022 (T+270)
2,074 shares0Common StockSEC:0001209191-21-038380
2,074 shares0Common StockSEC:0001209191-21-038380:0
3,253 shares0Common StockSEC:0001209191-21-038039:0
3,253 shares0Common StockSEC:0001209191-21-038039
4,000 shares@ US$379.530.0058% mcap33.0% of flowCommon StockSEC:0001127602-21-017616:0
4,000 shares@ US$379.5333.0% of flowCommon StockSEC:0001127602-21-017616
856 shares0Common StockSEC:0001179110-21-005074
856 shares0Common StockSEC:0001179110-21-005074:0
4,000 sharesCommon StockSEC:0001127602-21-015772
4,000 shares@ US$384.150.0059% mcap34.0% of flowCommon StockSEC:0001127602-21-015772:0
25 of 40 declarations
About FLATLEY JAY T
FLATLEY JAY T is a declarant who holds the position of Director at Denali Therapeutics Inc., Rivian Automotive, Inc. / DE, Illumina, INC., and Coherent Inc. He has also served as Chairman and Acting CEO of Zymergen Inc. In total, he has made 40 filings, all sampled, with a total buy amount of 5,585,817 EUR and a total sell amount of 3,762,732 EUR. His most recent filings range from January 14, 2016, to June 23, 2026. Among his notable filings, he bought 1,363,439.95 EUR worth of shares of Rivian Automotive, Inc. / DE on November 17, 2021.
